Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial.
Bennett C, Woo W, Bloch M, Cheung K, Griffin P, Mohan R, Deshmukh S, Arya M, Cumming O, Neville AM, McCallum Pardey TG, Plested JS, Cloney-Clark S, Zhu M, Kalkeri R, Patel N, Marcheschi A, Swan J, Smith G, Cho I, Glenn GM, Walker R, Mallory RM; Novavax 2019nCoV-311 Study Group. Bennett C, et al. Lancet Infect Dis. 2024 Mar 6:S1473-3099(24)00077-X. doi: 10.1016/S1473-3099(24)00077-X. Online ahead of print. Lancet Infect Dis. 2024. PMID: 38460525
Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial.
Feigl B, Lewis SJG, Burr LD, Schweitzer D, Gnyawali S, Vagenas D, Carter DD, Zele AJ. Feigl B, et al. Among authors: burr ld. EClinicalMedicine. 2024 Feb 10;69:102474. doi: 10.1016/j.eclinm.2024.102474. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361993 Free PMC article.
Pregnancy in women with cystic fibrosis and diabetes: An audit of outcomes at two tertiary obstetric hospitals in Australia in the pre-cystic fibrosis transmembrane conductance regulator modulator era.
Davidson SJ, France M, Callaway LK, Lust K, Chambers D, Hopkins P, Bell SC, Burr L, Keating R, Barrett HL. Davidson SJ, et al. Among authors: burr l. Obstet Med. 2023 Dec;16(4):217-221. doi: 10.1177/1753495X221146342. Epub 2022 Dec 25. Obstet Med. 2023. PMID: 38074210
Elevated BMI reduces the humoral response to SARS-CoV-2 infection.
Tong MZ, Sng JD, Carney M, Cooper L, Brown S, Lineburg KE, Chew KY, Collins N, Ignacio K, Airey M, Burr L, Joyce BA, Jayasinghe D, McMillan CL, Muller DA, Adhikari A, Gallo LA, Dorey ES, Barrett HL, Gras S, Smith C, Good-Jacobson K, Short KR. Tong MZ, et al. Among authors: burr l. Clin Transl Immunology. 2023 Dec 3;12(12):e1476. doi: 10.1002/cti2.1476. eCollection 2023. Clin Transl Immunology. 2023. PMID: 38050635 Free PMC article.
Interleukin-22 suppresses major histocompatibility complex II in mucosal epithelial cells.
Moniruzzaman M, Rahman MA, Wang R, Wong KY, Chen AC, Mueller A, Taylor S, Harding A, Illankoon T, Wiid P, Sajiir H, Schreiber V, Burr LD, McGuckin MA, Phipps S, Hasnain SZ. Moniruzzaman M, et al. Among authors: burr ld. J Exp Med. 2023 Nov 6;220(11):e20230106. doi: 10.1084/jem.20230106. Epub 2023 Sep 11. J Exp Med. 2023. PMID: 37695525 Free PMC article.
Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials.
Uluer AZ, MacGregor G, Azevedo P, Indihar V, Keating C, Mall MA, McKone EF, Ramsey BW, Rowe SM, Rubenstein RC, Taylor-Cousar JL, Tullis E, Yonker LM, Chu C, Lam AP, Nair N, Sosnay PR, Tian S, Van Goor F, Viswanathan L, Waltz D, Wang LT, Xi Y, Billings J, Horsley A; VX18-121-101; VX18-561-101 Study Groups. Uluer AZ, et al. Lancet Respir Med. 2023 Jun;11(6):550-562. doi: 10.1016/S2213-2600(22)00504-5. Epub 2023 Feb 23. Lancet Respir Med. 2023. PMID: 36842446 Free article. Clinical Trial.
152 results